Imaging & medical record review
MRI, CT, PET, pathology and prior treatment history are organized for structured multidisciplinary assessment.
Physician-led · Research-informed · United States & worldwide
Medicine,
rewritten at the molecular level.
A private, physician-led platform for advanced AAV gene therapy research and structured longevity medicine—with continuous clinical oversight.
Physician-led
AAV research focus
Worldwide coordination
Explicit regulatory framing
Our premise
The next frontier of medicine is not more noise. It is precision, governance and evidence.
Triple Helix Science brings molecular research into a disciplined, physician-led framework—built for careful inquiry, measured observation and responsible progress.
Our approach
Structured science. Continuous clinical oversight.
Unlike promotional longevity clinics, we operate as a physician-led research platform. Every engagement begins with rigorous assessment, clear jurisdictional boundaries, and continuous clinical oversight — not marketing claims.
01
AAV Vector Science
Focus on adeno-associated virus platforms for targeted gene delivery, informed by years of translational research and clinical observation.
Read more →02
Multi-Gene Research
Investigation of coordinated gene approaches, including pathways related to cellular resilience, cognitive function and metabolic support.
Read more →03
Physician Oversight
All clinical activity is directed by licensed physicians with extensive experience in interventional and regenerative medicine.
Meet the clinical leadership →04
Measured Outcomes
Emphasis on structured monitoring, biomarker tracking and transparent documentation of clinical observations over time.
Read more →37+
Years of medical experience
400+
Patients treated across clinical specialties and settings
50+
Peer-reviewed publications
Important notice.
The therapies and protocols discussed on this site are investigational or provided in specific clinical contexts outside the United States.
They are not approved by the U.S. Food and Drug Administration (FDA) for the prevention, treatment or cure of any disease.
Individual results vary. Participation is subject to medical suitability and local regulatory frameworks.
Interventional oncology · Worldwide network
Precision oncology built around the patient—not a single procedure.
Dr. Patrick E. Sewell and a multidisciplinary international team review complex cancer cases through image-guided, minimally invasive and precision-led perspectives. Each pathway begins with medical records, imaging and formal clinical review.
Worldwide
International case review and care coordination across jurisdictions. The location and availability of assessment or treatment depend on medical suitability, licensing, local regulation and the treating institution.
The team’s work may include evaluation of image-guided biopsy and ablation strategies, interventional radiology options, molecular diagnostics and coordination with oncology specialists. Recommendations are individualized and never replace urgent or locally required cancer care.
Image-guided treatment pathways
Evaluation of minimally invasive options within the context of diagnosis, disease stage and existing oncology care.
Molecular and clinical integration
Relevant molecular findings, biomarkers and clinical evidence are considered alongside imaging and standard-of-care options.
International specialist network
Patrick’s team coordinates physicians, specialists, researchers and administration around one controlled patient workspace.
Scientific foundation
From interventional oncology to molecular medicine.
Decades of interventional oncology and image-guided procedure experience inform a careful AAV-focused approach — distinct from plasmid or consumer longevity products.
Interventional Background
Extensive work in image-guided oncology, including pioneering contributions to percutaneous ablation techniques, provides the clinical foundation for later translational efforts.
Vector Design & Multi-Gene Research
Ongoing focus on AAV platform characteristics, coordinated gene approaches, safety considerations and targeted delivery strategies within regulated clinical environments.
Translational Observation
Clinical experience across multiple jurisdictions informs protocol design, monitoring frameworks and long-term follow-up practices.
Leadership
Dr. Patrick E. Sewell, MD
Founder · Chief Executive Officer · Chief Scientist
Dr. Sewell brings more than three decades of medical practice spanning interventional radiology, oncology and regenerative research. His formal training includes internal medicine, diagnostic radiology, interventional radiology and cross-sectional imaging.
He has contributed to early developments in image-guided cancer procedures and later directed substantial clinical work involving AAV-based gene delivery across international settings. His published research exceeds fifty peer-reviewed papers.
At Triple Helix Science he leads the scientific and clinical direction of the platform, with particular attention to protocol integrity, physician governance and responsible innovation.
Selected appearances
Conversations on gene therapy, longevity and clinical science.
YouTube
A New Era Against Cancer, Dementia & Aging
Extended conversation on AAV gene therapy, Klotho, Follistatin and clinical observations. Sober Head Podcast.
Watch interview →YouTube
Gene Therapy for Dementia and Longevity
Discussion with Robert Lufkin MD on hTERT, Klotho and translational gene therapy approaches.
Watch interview →YouTube
The Future of Cancer Treatment
Conversation on interventional oncology, image-guided procedures and the transition into gene therapy.
Watch interview →Application & contact
Begin with a confidential request.
A short application gives Patrick’s administrative team enough context to direct your request. The team coordinates initial enquiries and calls before clinical review. Do not send medical records by ordinary email.
01
Guided profile
Five short sections about goals, location and priorities.
02
Administrative review
Patrick’s team reviews the request, urgency and the right next conversation.
03
Clear next steps
If aligned, we outline pathway, timeline and governance.
Step 1 of 5
20%
Secure access
Triple Helix Workspace
Authorized access
Sign in with a secure email link.
Access is limited to authorized accounts. Do not use this service for emergencies.
Loading secure workspace…
Clinical & Regulatory Framework
Triple Helix Science is physician-led. Patrick’s international team includes licensed physicians, medical specialists, clinical administrators and researchers working within defined professional roles.
1. Licensed Clinical Leadership
Clinical assessment and treatment decisions are made by appropriately qualified and licensed clinicians. Each treating physician remains responsible for medical judgment, informed consent and patient care within the jurisdiction where care is delivered.
2. Website Information vs. Clinical Care
The public website provides general information and does not itself create a physician–patient relationship. Individual medical advice may be provided only after secure intake, identity verification, review of relevant records and formal acceptance by an appropriate clinician.
3. Treatment Status & Evidence
Some therapies, protocols or research areas discussed may be investigational, indication-specific or available only in defined clinical settings. Their regulatory status and evidence base vary by treatment, indication and country. No outcome is guaranteed; suitability and expected benefit must be assessed individually.
4. Worldwide Coordination, Local Responsibility
The team can review and coordinate cases internationally. The availability and location of any consultation, procedure or treatment remain subject to professional licensing, institutional governance, medical suitability and the laws and regulations of the relevant country.
5. Secure Records & Confidentiality
Medical records and imaging should be shared only through the secure Patient Portal. Access is role-based, limited to the assigned clinical team and recorded for governance.
6. Emergency Care
Triple Helix Science is not an emergency service. For urgent symptoms or immediate medical risk, contact local emergency services or the patient’s established treating team without delay.
7. Clinical & Regulatory Enquiries
For questions regarding the regulatory status of any referenced activity, please contact us at contact@triplehelix.to.